As filed with the Securities and Exchange Commission on March 22, 2024
Registration No. 333-259000
Registration No. 333-270576
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Post-Effective Amendment No. 1 to Registration Statement on Form S-8 (No. 333-259000)
Post-Effective Amendment No. 1 to Registration Statement on Form S-8 (No. 333-270576)
UNDER
THE SECURITIES ACT OF 1933
Cano Health,
Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware |
|
|
|
98-1524224 |
(State or other jurisdiction of incorporation or organization) |
|
|
|
(I.R.S. Employer Identification No.)
|
9725 NW 117th Avenue
Miami, Florida 33178
(Address of Principal Executive Offices, Including Zip Code)
Cano Health, Inc. 2021 Employee Stock Purchase Plan
Cano Health, Inc. 2021 Stock Option and Incentive Plan
(Full title of the plan)
Eladio Gil
Interim Chief Financial Officer
Cano Health, Inc.
9725
NW 117th Avenue
Miami, Florida 33178
(Name and address of agent for service)
Telephone: (855) 226-6633
(Telephone number, including area code, of Agent for Service)
Copies to:
Brian
V. Breheny
Skadden, Arps, Slate, Meagher & Flom LLP
1440 New York Avenue, N.W.
Washington, D.C. 20005
(202) 371-7180
Indicate by
check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large
accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☒ |
|
|
|
|
Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
☐ |
|
|
|
|
|
|
|
|
Emerging Growth company |
|
☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐